- 82nd Session (2023)
Senate Concurrent Resolution No. 5–Senator Lange
FILE NUMBER..........
SENATE CONCURRENT RESOLUTION—Urging the expansion
of comprehensive cardiovascular screening programs and
directing the Joint Interim Standing Committee on Health
and Human Services to conduct a study concerning such
programs and certain other matters relating to cardiovascular
disease.
WHEREAS, The Centers for Disease Control and Prevention of
the United States Department of Health and Human Services has
stated that cardiovascular disease is the leading cause of death in the
United States; and
WHEREAS, According to the Centers for Disease Control and
Prevention, approximately 20.1 million people have been diagnosed
with atherosclerotic cardiovascular disease and are at risk of a
cardiovascular event; and
WHEREAS, The Mayo Clinic has stated that atherosclerotic
cardiovascular disease is linked to cholesterol accumulating in the
arteries and the risk of associated cardiovascular events may be
reduced by lowering low-density lipoprotein cholesterol; and
WHEREAS, According to a report from the American Heart
Association, in 2016, nearly 68 million adults in the United States
had a high level of low-density lipoprotein cholesterol; and
WHEREAS, The Centers for Disease Control and Prevention has
reported that 47 million people in the United States are currently
receiving medication to lower their level of low-density lipoprotein
cholesterol and thereby manage their risk of a cardiovascular event;
and
WHEREAS, Data from the National Health and Nutrition
Examination Survey in 2011-2012 provides that only approximately
20 percent of people with atherosclerotic cardiovascular disease
who are taking statins, a leading therapy to lower low-density
lipoprotein cholesterol, are successfully reducing their level of low-
density lipoprotein cholesterol to a healthy level; and
WHEREAS, According to the American Heart Association, the
total direct and indirect cost of atherosclerotic cardiovascular
disease in the United States was $555 billion in 2016 and is
projected to reach $1.1 trillion by 2035; and
WHEREAS, The Centers for Disease Control and Prevention has
stated that health care professionals in Nevada have diagnosed 8
percent of adults in this State with a symptom of atherosclerotic
– 2 –
- 82nd Session (2023)
cardiovascular disease, including, without limitation, an angina,
stroke, heart attack or coronary heart disease; now, therefore, be it
RESOLVED BY THE SENATE OF THE STATE OF NEVADA, THE
ASSEMBLY CONCURRING, That the members of the 82nd Session of
the Nevada Legislature urge state agencies to expand
comprehensive cardiovascular screening programs to allow for
earlier identification of patients at risk of cardiovascular events; and
be it further
RESOLVED, That the members of the 82nd Session of the
Nevada Legislature urge state agencies to explore ways to
collaborate with federal agencies and national organizations to
establish or expand comprehensive cardiovascular screening
programs; and be it further
RESOLVED, That the members of the 82nd Session of the
Nevada Legislature urge state agencies to evaluate programs to
improve cardiovascular health which are operating in this State for
the purpose of accelerating improvements in the care rendered to
patients at risk of cardiovascular events such that improvements in
screening, treatment, monitoring and health outcomes are achieved;
and be it further
RESOLVED, That the members of the 82nd Session of the
Nevada Legislature urge the development of policies to reduce the
number of Americans who die as a result of atherosclerotic
cardiovascular disease; and be it further
RESOLVED, That the members of the 82nd Session of the
Nevada Legislature direct the Joint Interim Standing Committee on
Health and Human Services to conduct a study during the
2023-2024 interim concerning cardiovascular screening programs
that are currently operating in this State, ways for state agencies to
collaborate with federal agencies and private organizations in the
evaluation and expansion of such programs and other matters
relating to cardiovascular disease; and be it further
RESOLVED, That the study must include a review of the Get
With The Guidelines program of the American Heart Association,
the degree to which the program has been adopted by health
facilities in this State and the success of the program where adopted
by health facilities in this State; and be it further
RESOLVED, That the study must consider the provision of
reimbursement under the Medicaid program for the remote
monitoring of cardiovascular health; and be it further
RESOLVED, That the study must include a review of the
implementation of Complete Streets Programs pursuant to NRS
403.575 and the identification of gaps in reforms to zoning laws in
– 3 –
- 82nd Session (2023)
order to promote zoning that is more conducive to good
cardiovascular health; and be it further
RESOLVED, That, pursuant to subsection 4 of NRS 218E.330,
the Committee shall submit a report of the study and any
recommendations for legislation to the Director of the Legislative
Counsel Bureau for transmittal to the 83rd Session of the Nevada
Legislature; and be it further
RESOLVED, That the Secretary of the Senate prepare and
transmit a copy of this resolution to the President of the United
States, the Vice President of the United States, members of the
United States House of Representatives and United States Senate
and other federal and state government officials and agencies as
appropriate; and be it further
RESOLVED, That this resolution becomes effective upon
adoption.
20 ~~~~~ 23